InvestorsHub Logo
Followers 79
Posts 24450
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 09/17/2020 7:04:30 AM

Thursday, September 17, 2020 7:04:30 AM

Post# of 27354
SRNE - 8.36 Pre-market at 10.69/10.70

BZ: Sorrento Therapeutics shares are trading higher after the company announced it received FDA clearance to proceed with its Phase 1 Clinical trial of its STI-1499 Neutralizing antibody in coronavirus positive patient.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.